Literature DB >> 15722255

Autoimmune hazards of hepatitis B vaccine.

Marc Girard1.   

Abstract

According to Hippocratic tradition, the safety level of a preventive medicine must be very high, as it is aimed at protecting people against diseases that they may not contract. This paper points out that information on the safety of hepatitis B vaccine (HBV) is biased as compared to classical requirements of evidence-based medicine (EBM), as exemplified by a documented selectivity in the presentation or even publication of available clinical or epidemiological data. Then, a review is made of data suggesting that HBV is remarkable by the frequency, the severity and the variety of its complications, some of them probably related to a mechanism of molecular mimicry leading to demyelinating diseases, and the others reproducing the spectrum of non-hepatic manifestations of natural hepatitis B. To be explained, this unusual spectrum of toxicity requires additional investigations based upon complete release of available data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722255     DOI: 10.1016/j.autrev.2004.10.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  4 in total

Review 1.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

Review 2.  Hepatitis B virus (HBV) and autoimmune disease.

Authors:  Ram Maya; M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

3.  HBV vaccine and dermatomyositis: is there an association?

Authors:  Arie Altman; Martine Szyper-Kravitz; Yehuda Shoenfeld
Journal:  Rheumatol Int       Date:  2007-11-23       Impact factor: 3.580

4.  Toward a theory of childhood learning disorders, hyperactivity, and aggression.

Authors:  Anthony R Mawson
Journal:  ISRN Psychiatry       Date:  2012-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.